Ownership as of December 30, 2019. Twenty largest shareholders.
NameSeries A sharesSeries B sharesShare capital %Voting rights %
ANNWALL & ROTHSCHILD INVESTMENTS AB377 736410 4787,0228,63
FJÄRDE AP FONDEN-1 111 1119,907,60
ÖHMAN BANK S.A.-1 098 4529,787,51
SWEDBANK ROBUR NY TEKNIK BTI-579 1725,163,96
TREDJE AP-FONDEN-510 0004,543,49
AMF AKTIEFOND SMÅBOLAG-501 5854,473,43
UNIONEN-447 1963,983,06
SKANDINAVISKA ENSKILDA BANKEN AB, W8IMY-311 3502,772,13
CBNY-NORGES BANK-317 3002,602,00
DANGOOR, DAVID-290 1442,581,98
HANDELSBANKEN SVENSKA, SMABOLAGSFOND-263 7812,351,80
ANDRA AP-FONDEN-263 5002,351,80
BANQUE PICTET & CIE SA, W8IMY (WITHOUT P.R.-252 5822,251,73
SWEDBANK ROBUR MICROCAP-250 0002,231,71
RBC INVESTOR SERVICES BANK S.A-228 8832,041,56
ÅLANDSBANKEN I ÄGARES STÄLLE-228 7302,041,56
NORDNET PENSIONSFÖRSÄKRING AB-209 7971,871,43
HANDELSBANKEN MICROCAP SVERIGE-199 6011,781,36
FÖRSÄKRINGSAKTIEBOLAGET, AVANZA PENSION-187 7631,671,28
CATELLA SMÅBOLAGSFOND-160 0001,431,09
Sub-total377 7367 821 42572,8179,11
Other shareholders-3 027 02327,1920,89
Total377 73610 848 448100100
Source: Euroclear Sweden AB
The total registered share capital of Infant Bacterial Therapeutics AB consists of 377,736 class A shares with 10 votes per share and 10,848,448 class B shares with one vote per share, in total 11,226,184 shares.